T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study

Authors :: Andrzej Horban
Graham R. Foster
I. Lonjon-Domanec
G. Picchio
E.J. Lawitz
R. van Heeswijk
P. Andreone
S. Zeuzem
Stanislas Pol
Z.M. Younossi
Steven Roberts
Moisés Diago
Ralph DeMasi
R. Focaccia
James Witek
S. DeMeyer
Source :: Digestive and Liver Disease. 44:S23
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: medicine.medical_specialty
Hepatology
Hcv genotype 1
business.industry
Internal medicine
Gastroenterology
Medicine
PEGINTERFERON/RIBAVIRIN
business
Treatment failure
Telaprevir
medicine.drug

Tools